Published

Psychedelic Psychiatry's Brave New World.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Cell
Date: 2020-04-02
Source: PubMed
DOI: 10.1016/j.cell.2020.03.020
PubMed: 32243793

Authors

Nutt D Erritzoe D Carhart-Harris R

Watch author

Derived topics and classifications

psilocybin Depression Addiction Receptor Pharmacology Other

Citation graph

0 referenced DOIs found in stored source metadata. 7 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress2026-09-01 Evaluating psilocybin for the management of depression: a literature review2026-08-02 Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions2026-07-03 Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study2026-07-01 A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression2026-04-06 Explainable AI framework for psilocybin depression treatment optimization2026-03-16 The effect of psilocin on neurotransmitters release in the claustrum and on rat behavior2026-02-01

Related papers

Psychedelics as Medicines: An Emerging New Paradigm.Clinical pharmacology and therapeutics · 2017-02-01 Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders.CNS & neurological disorders drug targets · 2026-03-11 Medical Uses and Adverse Effects of Psilocybin.The primary care companion for CNS disorders · 2024-05-28 Exposure to Potent Hallucinogens in an AdolescentThe Primary Care Companion For CNS Disorders · 2013-10-23 Psychedelics: Historical Context, Emerging Science, and Future Clinical FrontiersJournal of Mental Health Disorders · 2026-04-18 Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use DisorderClinicalTrials.gov · 2026-03-30 With great power comes great responsibility: Promise and caution in the new psychedelic renaissanceBrain Disorders · 2025-09-23 Psychedelics in the treatment of unipolar and bipolar depression.International journal of bipolar disorders · 2022-07-05